“We are happy to support such a landmark project, which will further strengthen the Stockholm area as a leading life science cluster,” said EIB Vice-President Eva Srejber, adding: “This loan is also a key element in the EIB’s participation in the EU strategy for the Baltic Sea Region, as it promotes research, development and innovation in line with the objectives of the strategy.”
Background notes:
The mission of the EIB, the European Union’s bank, is to contribute to the integration, balanced development and economic and social cohesion of the EU Member States by financing sound investments. The EIB raises substantial volumes of funds on the capital markets which it lends on favourable terms to projects that further EU policy objectives. The EIB operates on a non-profit maximising basis and lends at close to the cost of borrowing. The Bank's consistent AAA rating is underpinned by firm shareholder support, a strong capital base, exceptional asset quality, conservative risk management and a sound funding strategy.